Essex Investment Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,757	Closed	-$665K	–	321
2015 Q2	$665K	Sell	1,757 -141	-7%	-$53.4K	0.1%	208
2015 Q1	$793K	Buy	+1,898	New	+$793K	0.11%	191